| Issue |
Section |
Title |
File |
| Vol 96, No 2 (2020) |
EDITORIAL |
Recommendations Russian Society of Dermatovenerologists and Cosmetologists
for systemic treatment of psoriasis during the pandemic COVID-19 |
(Rus)
|
| Vol 97, No 2 (2021) |
REVIEWS |
Revisiting the question of pemphigus classification |
(Rus)
|
| Vol 97, No 2 (2021) |
CLINICAL PRACTICE GUIDELINES |
Clinical evidence of therapy for genital psoriasis by biologic agents |
(Rus)
|
| Vol 97, No 4 (2021) |
ORIGINAL STUDIES |
Efficacy and safety of netakimab, a novel anti-IL-17 monoclonal antibody, in patients with moderate to severe plaque psoriasis. Results of a 54-week randomized double-blind placebo-controlled PLANETA clinical trial |
(Rus)
|
| Vol 97, No 4 (2021) |
REVIEWS |
Revisiting the question of cutaneous vasculitis classification |
(Rus)
|
| Vol 98, No 2 (2022) |
ORIGINAL STUDIES |
Efficacy and safety profile of 2-year netakimab treatment in patients with moderate-to-severe plaque psoriasis in terms of the randomized double-blind placebo-controlled BCD-085-7/PLANETA clinical trial |
(Rus)
|
| Vol 98, No 5 (2022) |
REVIEWS |
Revisiting the question of toxidermia classification |
(Rus)
|
| Vol 100, No 2 (2024) |
REVIEWS |
Hidradenitis suppurativa: definition, epidemiology, etiology, diagnosis (part 1) |
(Rus)
|
| Vol 100, No 3 (2024) |
REVIEWS |
Hidradenitis suppurativa: review of international clinical guidelines for the diagnosis and treatment of the disease |
(Rus)
|
| Vol 101, No 4 (2025) |
ORIGINAL STUDIES |
Results of CRYSTAL retrospective observational study in Russia: severity of the disease, treatment landscapes and quality of life in patients with moderate to severe psoriasis receiving systemic therapy in routine clinical practice |
(Rus)
|
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).